Thomas Patrick Kelly Insider Profile

11 Followers
Thomas Patrick Kelly, CFO & SVP Finance & Corp. Dev, at Cornerstone Therapeutics Inc, holds 0.00 shares in Cornerstone Therapeutics Inc (Ticker: ~CRTX), holds 0.00 shares in Deciphera Pharmaceuticals (Ticker: DCPH). Most recently, Thomas Patrick Kelly ― shares of Cornerstone Therapeutics Inc on ― for an estimated value of ―.
tipranks
Thomas Patrick Kelly

Thomas Patrick Kelly
Cornerstone Therapeutics Inc (~CRTX)
CFO & SVP Finance & Corp. Dev,

Ranked #71,260 out of 99,218 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

-12.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Thomas Patrick Kelly does not currently own shares as a corporate insider.
A breakdown of Thomas Patrick Kelly's holdings

Insider Roles

Thomas Patrick Kelly does not currently hold a role as a corporate insider.
Roles that Thomas Patrick Kelly holds in companies

Most Profitable Insider Trade

Stock:
Deciphera Pharmaceuticals
(DCPH)
Rating:Informative Sell
Date:Feb 18, 2021 - Feb 18, 2022
Return:+82.30%
The most profitable trade made by Thomas Patrick Kelly

Thomas Patrick Kelly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~CRTX
Cornerstone Therapeutics Inc
DCPH
Deciphera Pharmaceuticals
Jun 11, 2024
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Thomas Patrick Kelly's performance on stock

Thomas Patrick Kelly insider profile FAQ

What is the percentage of profitable transactions made by Thomas Patrick Kelly?
The percentage of profitable transactions made by Thomas Patrick Kelly is 33%.
    What is the average return per transaction made by Thomas Patrick Kelly?
    The average return per transaction made by Thomas Patrick Kelly is -12.10%.
      What stocks does Thomas Patrick Kelly hold?
      Thomas Patrick Kelly holds: ~CRTX, DCPH stocks.
        What was Thomas Patrick Kelly’s latest transaction?
        Thomas Patrick Kelly latest transaction was an Uninformative Buy of ―.
          What was Thomas Patrick Kelly's most profitable transaction?
          Thomas Patrick Kelly’s most profitable transaction was an Informative Sell of DCPH stock on February 18, 2021. The return on the trade was 82.30%.
            What is Thomas Patrick Kelly's role in Cornerstone Therapeutics Inc?
            Thomas Patrick Kelly's role in Cornerstone Therapeutics Inc is CFO & SVP Finance & Corp. Dev,.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.